RecruitingNot ApplicableNCT06591169

Lifestyle Changes in PCOS with OSA and NAFLD

Polycystic Ovarian Syndrome Women with NAFLD and Obstructive Sleeping Apnea: Program of Lifestyle Changes

Sponsor

Cairo University

Enrollment

40 participants

Start Date

Jul 5, 2024

Study Type

INTERVENTIONAL

Conditions

PCOS NAFLD OSA

Summary

Complain of obstructive sleeping apnea and fatty liver is common in PCOS women so lifestyle changes are recommended

Eligibility

Sex: FEMALEMin Age: 30 YearsMax Age: 40 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a behavioral approach called diet restriction and a behavioral approach called diet restriction and exercise for people with nafld, osa, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 30 Years to 40 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALdiet restriction and exercise

this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake, and daily walking for 30 minutes

BEHAVIORALdiet restriction

this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily) and program of low diet intake

Locations(2)

faculty of physical therapy Cairo university

Dokki, Giza Governorate, Egypt

faculty of physical therapy Cairo university

Dokki, Giza Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06591169

Related Trials

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NCT054240031 location

Lifestyle Changes in PCOS with OSA and NAFLD

Conditions

Summary

Eligibility

Plain Language Summary

Interventions

Locations(2)

Related Trials

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

Bicalutamide Therapy in Young Women With NAFLD and PCOS

Digoxin In NASH (CODIN)

Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis

Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals